239 related articles for article (PubMed ID: 23963728)
1. Mechanistic study of the uptake/permeation of cell-penetrating peptides across a caco-2 monolayer and their stimulatory effect on epithelial insulin transport.
Kamei N; Onuki Y; Takayama K; Takeda-Morishita M
J Pharm Sci; 2013 Nov; 102(11):3998-4008. PubMed ID: 23963728
[TBL] [Abstract][Full Text] [Related]
2. Effects of intestinal luminal contents and the importance of microfold cells on the ability of cell-penetrating peptides to enhance epithelial permeation of insulin.
Kamei N; Kawano S; Abe R; Hirano S; Ogino H; Tamiwa H; Takeda-Morishita M
Eur J Pharm Biopharm; 2020 Oct; 155():77-87. PubMed ID: 32781024
[TBL] [Abstract][Full Text] [Related]
3. Effect of different intestinal conditions on the intermolecular interaction between insulin and cell-penetrating peptide penetratin and on its contribution to stimulation of permeation through intestinal epithelium.
Kamei N; Aoyama Y; Khafagy el-S; Henmi M; Takeda-Morishita M
Eur J Pharm Biopharm; 2015 Aug; 94():42-51. PubMed ID: 25960330
[TBL] [Abstract][Full Text] [Related]
4. Noncovalent Strategy with Cell-Penetrating Peptides to Facilitate the Brain Delivery of Insulin through the Blood-Brain Barrier.
Kamei N; Yamaoka A; Fukuyama Y; Itokazu R; Takeda-Morishita M
Biol Pharm Bull; 2018; 41(4):546-554. PubMed ID: 29607927
[TBL] [Abstract][Full Text] [Related]
5. Effect of cell-penetrating peptides on the nasal absorption of insulin.
Khafagy el-S; Morishita M; Isowa K; Imai J; Takayama K
J Control Release; 2009 Jan; 133(2):103-8. PubMed ID: 18930084
[TBL] [Abstract][Full Text] [Related]
6. Oligoarginine-modified biodegradable nanoparticles improve the intestinal absorption of insulin.
Liu X; Liu C; Zhang W; Xie C; Wei G; Lu W
Int J Pharm; 2013 May; 448(1):159-67. PubMed ID: 23538098
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of cell-penetrating peptides to improve intestinal insulin absorption.
Kamei N; Morishita M; Eda Y; Ida N; Nishio R; Takayama K
J Control Release; 2008 Nov; 132(1):21-5. PubMed ID: 18727945
[TBL] [Abstract][Full Text] [Related]
8. Applicability and Limitations of Cell-Penetrating Peptides in Noncovalent Mucosal Drug or Carrier Delivery Systems.
Kamei N; Bech Nielsen EJ; Nakakubo T; Aoyama Y; Rahbek UL; Pedersen BL; Takeda-Morishita M
J Pharm Sci; 2016 Feb; 105(2):747-753. PubMed ID: 26869427
[TBL] [Abstract][Full Text] [Related]
9. Exploration of the Key Factors for Optimizing the in Vivo Oral Delivery of Insulin by Using a Noncovalent Strategy with Cell-Penetrating Peptides.
Kamei N; Shigei C; Hasegawa R; Takeda-Morishita M
Biol Pharm Bull; 2018; 41(2):239-246. PubMed ID: 29386483
[TBL] [Abstract][Full Text] [Related]
10. A cell-penetrating peptide conjugated carboxymethyl-β-cyclodextrin to improve intestinal absorption of insulin.
Yang L; Li M; Sun Y; Zhang L
Int J Biol Macromol; 2018 May; 111():685-695. PubMed ID: 29343452
[TBL] [Abstract][Full Text] [Related]
11. Enhanced oral bioavailability of insulin using PLGA nanoparticles co-modified with cell-penetrating peptides and Engrailed secretion peptide (Sec).
Zhu S; Chen S; Gao Y; Guo F; Li F; Xie B; Zhou J; Zhong H
Drug Deliv; 2016 Jul; 23(6):1980-91. PubMed ID: 26181841
[TBL] [Abstract][Full Text] [Related]
12. Molecular imaging analysis of intestinal insulin absorption boosted by cell-penetrating peptides by using positron emission tomography.
Kamei N; Morishita M; Kanayama Y; Hasegawa K; Nishimura M; Hayashinaka E; Wada Y; Watanabe Y; Takayama K
J Control Release; 2010 Aug; 146(1):16-22. PubMed ID: 20457194
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Cell-Penetrating Peptides as Versatile, Effective Absorption Enhancers: Relation to Molecular Weight and Inherent Epithelial Drug Permeability.
Kamei N; Yamanaka J; Oda Y; Kaneoka S; Koide Y; Haruna Y; Takahashi Y; Tamiwa H; Takeda-Morishita M
Pharm Res; 2020 Sep; 37(10):182. PubMed ID: 32888051
[TBL] [Abstract][Full Text] [Related]
14. In vivo proof of concept of oral insulin delivery based on a co-administration strategy with the cell-penetrating peptide penetratin.
Nielsen EJ; Yoshida S; Kamei N; Iwamae R; Khafagy el-S; Olsen J; Rahbek UL; Pedersen BL; Takayama K; Takeda-Morishita M
J Control Release; 2014 Sep; 189():19-24. PubMed ID: 24973720
[TBL] [Abstract][Full Text] [Related]
15. Region-Dependent Role of Cell-Penetrating Peptides in Insulin Absorption Across the Rat Small Intestinal Membrane.
Khafagy el-S; Iwamae R; Kamei N; Takeda-Morishita M
AAPS J; 2015 Nov; 17(6):1427-37. PubMed ID: 26216471
[TBL] [Abstract][Full Text] [Related]
16. Facilitated nanoscale delivery of insulin across intestinal membrane models.
Woitiski CB; Sarmento B; Carvalho RA; Neufeld RJ; Veiga F
Int J Pharm; 2011 Jun; 412(1-2):123-31. PubMed ID: 21501675
[TBL] [Abstract][Full Text] [Related]
17. A novel approach using functional peptides for efficient intestinal absorption of insulin.
Morishita M; Kamei N; Ehara J; Isowa K; Takayama K
J Control Release; 2007 Apr; 118(2):177-84. PubMed ID: 17270307
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive insulin delivery: the great potential of cell-penetrating peptides.
Kamei N; Nielsen EJ; Khafagy el-S; Takeda-Morishita M
Ther Deliv; 2013 Mar; 4(3):315-26. PubMed ID: 23442079
[TBL] [Abstract][Full Text] [Related]
19. PEG-PGA enveloped octaarginine-peptide nanocomplexes: An oral peptide delivery strategy.
Niu Z; Samaridou E; Jaumain E; Coëne J; Ullio G; Shrestha N; Garcia J; Durán-Lobato M; Tovar S; Santander-Ortega MJ; Lozano MV; Arroyo-Jimenez MM; Ramos-Membrive R; Peñuelas I; Mabondzo A; Préat V; Teixidó M; Giralt E; Alonso MJ
J Control Release; 2018 Apr; 276():125-139. PubMed ID: 29518466
[TBL] [Abstract][Full Text] [Related]
20. Oligoarginine-linked polymers as a new class of penetration enhancers.
Sakuma S; Suita M; Masaoka Y; Kataoka M; Nakajima N; Shinkai N; Yamauchi H; Hiwatari K; Tachikawa H; Kimura R; Yamashita S
J Control Release; 2010 Dec; 148(2):187-96. PubMed ID: 20800631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]